Toll Free: 1-888-928-9744
Toll Free: 1-888-928-9744
Published: Dec, 2018 | Pages:
120 | Publisher: Grand View Research
Industry: Healthcare | Report Format: Electronic (PDF)
The global amniotic membrane market size is expected to reach USD 5.81 billion by 2025, according to a new report by Grand View Research, Inc. The market is estimated to witness a CAGR of 12.6% during the forecast period. Rise in trauma, burn cases and resulting surgeries along with increasing awareness regarding the benefits of these products are boosting the market growth. Rising number of cosmetic surgeries performed is also anticipated to drive the market during the forecast period. Amniotic membrane is also used in the treatment of a large number of ocular surface diseases as it protects surfaces from microbial colonization preventing the risk of infections. Moreover, presence of growth factors including basic Fibroblast Growth Factor (bFGF), Transforming Growth Factors (TGFs), Epidermal Growth Factor (EGF), Vascular Endothelial Growth Factor (VEGF), Nerve Growth Factor (NGF), and Keratinocyte Growth Factor (KGF) in amniotic membranes promote wound healing, accelerating its adoption globally. Thus, its benefits, such as anti-inflammatory properties, reduced fibrosis and scarring at the site of surgery, pain reduction, and wound healing properties, are also fueling the demand. These products are thus most commonly used in surgeries, treatment of venous, pressure, and diabetic foot ulcers, ophthalmology, and in the management of chronic wounds. The American Association of Tissue Banks is a non-profit organization that regulates tissue donation in U.S. Presence of such tissue banks ensures zero disease transmission, which, in turn, propels market growth. Furthermore, a number of institutes are trying to introduce novel areas of applications for these products by focusing on the research activities in stem cell and regenerative medicines. This factor is also likely to support market expansion. The use of cryopreserved amniotic membrane is largely seen in hospitals, Ambulatory Surgical Centers (ASCs), and specialty clinics. Lyophylization of the tissue post donation preserves the histological and biological activity of the tissue facilitating faster wound recovery. Further key findings from the study suggest: • Cryopreserved is expected to be the dominant segment in future as it's highly effective and ensures preservation of histological and biological properties • Surgical wounds segment is projected to witness high growth due to increasing usage of these products for surgical applications • Specialty clinics are anticipated to register the highest CAGR during the forecast period due to increasing number of cosmetic and reconstructive surgeries being performed • North America is a leading regional market owing to presence of a large number of key companies and high incidence of chronic and infectious diseases • The Asia Pacific region is expected to record the highest CAGR during the forecast period due to growing population and rising incidence of chronic diseases and burn injuries • Major companies in the amniotic membrane market include Alliqua BioMedical Inc.; Amnio Technology, Applied Biologics LLC; Human Regenerative Technologies DermaSciences; Katena Products, MiMedx Group Inc.; and Skye Biologics, Inc.
Table of Contents
Chapter 1 Executive Summary
Chapter 2 Research Methodology
2.1 Country-wise Market: Base Estimates
2.2 Global Market: CAGR Calculation
2.3 Region-based Segment Share Calculation
2.4 Research Scope & Assumptions
2.5 List of Data Sources
2.5.1 Data for primary interviews, by sources
2.5.2 Data for primary interviews, by region
2.6 Market Snapshot
Chapter 3 Amniotic Membrane Market Variables, Trends & Scope
3.1 Market Segmentation & Scope
3.2 Market Driver Analysis
3.2.1 Rising research on stem cell biology and regenerative medicine
3.2.2 Increasing awareness towards benefits offered by amniotic membrane
3.2.3 Rise in the number of accident and trauma cases
3.3 Market Restraint Analysis
3.3.1 Lack of skilled professionals
3.3.2 Lack of standardized guidelines
3.4 Key Opportunities Prioritized
3.4.1 Key opportunities prioritized, by product
3.4.2 Key opportunities prioritized, by application
3.4.3 Key opportunities prioritized, by end use
3.5 Amnitoic Membrane Market - SWOT Analysis, by Factor (Political & Legal, Economic and Technological)
3.6 Industry Analysis - Porter's
3.7 Amnitoic Membrane Market: Company Market Position Analysis, 2017
Chapter 4 Amnitoic Membrane Market: Enzyme Estimates & Trend Analysis
4.1 Amnitoic Membrane Market: Product Movement Analysis
4.2 Cryopreserved Amniotic Membrane
4.2.1 Cryopreserved amniotic membrane market, 2014 - 2025 (USD Million)
4.3 Dehydrated Amniotic Membrane
4.3.1 Dehydrated amniotic membrane market, 2014 - 2025 (USD Million)
Chapter 5 Amnitoic Membrane Market: Application Estimates & Trend Analysis
5.1 Amnitoic Membrane Market: Application Movement Analysis
5.2 Surgical Wounds
5.2.1 Surgical wounds market, 2014 - 2025 (USD Million)
5.3 Ophthalmology
5.3.1 Ophthalmology market, 2014 - 2025 (USD Million)
5.4 Others
5.4.1 Others market, 2014 - 2025 (USD Million)
Chapter 6 Amnitoic Membrane Market: End Use Estimates & Trend Analysis
6.1 Amnitoic Membrane Market: End Use Movement Analysis
6.2 Hospitals
6.2.1 Hospitals market, 2014 - 2025 (USD Million)
6.3 Ambulatory Surgical Clinics
6.3.1 Ambulatory surgical clinics market, 2014 - 2025 (USD Million)
6.4 Specialty Clinics
6.4.1 Specialty clinics market, 2014 - 2025 (USD Million)
6.5 Research and Academic Institutes
6.5.1 Research and academic institutes market, 2014 - 2025 (USD Million)
Chapter 7 Amnitoic Membrane Market: Regional Estimates & Trend Analysis, by Product, Application, and End Use
7.1 Amniotic Membrane Market Share, by Region, 2017 & 2025
7.2 North America
7.2.1 Market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.2.2 Market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.2.3 Market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.2.4 U.S.
7.2.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.2.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.2.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.2.5 Canada
7.2.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.2.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.2.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.3 Europe
7.3.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.3.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.3.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.3.4 U.K.
7.3.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.3.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.3.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.3.5 Germany
7.3.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.3.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.3.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.4 Asia Pacific
7.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.4.4 Japan
7.4.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.4.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.4.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.4.5 China
7.4.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.4.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.4.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.4.6 India
7.4.6.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.4.6.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.4.6.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.5 Latin America
7.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.5.4 Brazil
7.5.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.5.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.5.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.5.5 Mexico
7.5.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.5.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.5.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.6 Middle East & Africa (MEA)
7.6.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.6.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.6.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.6.4 South Africa
7.6.4.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.6.4.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.6.4.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
7.6.5 Saudi Arabia
7.6.5.1 market estimates and forecasts, by product, 2014 - 2025 (USD Million)
7.6.5.2 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
7.6.5.3 market estimates and forecasts, by end use, 2014 - 2025 (USD Million)
Chapter 8 Competitive Landscape
8.1 Company Profiles
8.1.1 Alliqua BioMedical Inc.
8.1.1.1 Company overview
8.1.1.2 Product benchmarking
8.1.1.3 Financial Performance
8.1.1.4 Strategic Initiatives
8.1.2 Amnio Technology, LLC
8.1.2.1 Company overview
8.1.2.2 Financial performance
8.1.2.3 Product benchmarking
8.1.2.4 Strategic Initiatives
8.1.3 Applied Biologics LLC
8.1.3.1 Company overview
8.1.3.2 Financial performance
8.1.3.3 Product benchmarking
8.1.3.4 Strategic Initiatives
8.1.4 Human Regenerative Technologies, LLC
8.1.4.1 Company overview
8.1.4.2 Financial performance
8.1.4.3 Product benchmarking
8.1.4.4 Strategic initiatives
8.1.5 DermaSciences.
8.1.5.1 Company overview
8.1.5.2 Financial performance
8.1.5.3 Product benchmarking
8.1.5.4 Strategic Initiatives
8.1.6 Katena Products, Inc.
8.1.6.1 Company overview
8.1.6.2 Financial performance
8.1.6.3 Product benchmarking
8.1.6.4 Strategic initiatives
8.1.7 MiMedx Group Inc.
8.1.7.1 Company overview
8.1.7.2 Financial performance
8.1.7.3 Product benchmarking
8.1.7.4 Strategic initiatives
8.1.8 Skye Biologics, Inc.
8.1.8.1 Company overview
8.1.8.2 Financial performance
8.1.8.3 Product benchmarking
8.1.8.4 Strategic initiatives
8.1.9 Amniox Medical Inc.
8.1.9.1 Company overview
8.1.9.2 Financial performance
8.1.9.3 Product benchmarking
8.1.9.4 Strategic initiatives
8.1.10 Integra LifeSciences
8.1.10.1 Company overview
8.1.10.2 Financial performance
8.1.10.3 Product benchmarking
8.1.10.4 Strategic initiatives
List of Tables TABLE 1 Factors used in segment share estimation TABLE 2 List of secondary data sources TABLE 3 North America amniotic membrane market, by country, 2014 - 2025 (USD Million) TABLE 4 North America amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 5 North America amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 6 North America amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 7 U.S. amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 8 U.S. amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 9 U.S. amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 10 Canada amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 11 Canada amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 12 Canada amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 13 Europe amniotic membrane market, by country, 2014 - 2025 (USD Million) TABLE 14 Europe amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 15 Europe amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 16 Europe amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 17 U.K. amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 18 U.K. amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 19 U.K. amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 20 Germany amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 21 Germany amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 22 Germany amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 23 Asia Pacific amniotic membrane market, by country, 2014 - 2025 (USD Million) TABLE 24 Asia Pacific amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 25 Asia Pacific amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 26 Asia Pacific amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 27 Japan amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 28 Japan amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 29 Japan amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 30 China amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 31 China amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 32 China amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 33 India amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 34 India amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 35 India amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 36 Latin America amniotic membrane market, by country, 2014 - 2025 (USD Million) TABLE 37 Latin America amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 38 Latin America amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 39 Latin America amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 40 Brazil amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 41 Brazil amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 42 Brazil amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 43 Mexico amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 44 Mexico amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 45 Mexico amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 46 MEA amniotic membrane market, by country, 2014 - 2025 (USD Million) TABLE 47 MEA amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 48 MEA amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 49 MEA amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 50 South Africa amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 51 South Africa amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 52 South Africa amniotic membrane market, by end use, 2014 - 2025 (USD Million) TABLE 53 Saudi Arabia amniotic membrane market, by product, 2014 - 2025 (USD Million) TABLE 54 Saudi Arabia amniotic membrane market, by application, 2014 - 2025 (USD Million) TABLE 55 Saudi Arabia amniotic membrane market, by end use, 2014 - 2025 (USD Million)
List of Figures FIG. 1 Primary interviews, by sources FIG. 2 Primary interviews, by region FIG. 3 Market summary (USD Million) FIG. 4 Market trends & outlook FIG. 5 Market segmentation & scope FIG. 6 Market driver relevance analysis (Current & future impact) FIG. 7 Market restraint relevance analysis (Current & future impact) FIG. 8 Key opportunities prioritized, by product FIG. 9 Key opportunities prioritized, by application FIG. 10 Key opportunities prioritized, by end use FIG. 11 SWOT analysis, by factor (political & legal, economic and technological) FIG. 12 Porter's Five Forces Analysis FIG. 13 Amniotic membrane market: Heat map analysis, 2017 FIG. 14 Amniotic membrane market, product outlook: Key takeaways FIG. 15 Amniotic membrane market: product movement analysis FIG. 16 Cryopreserved amniotic membrane market, 2014 - 2025 (USD Million) FIG. 17 Dehydrated amniotic membrane market, 2014 - 2025 (USD Million) FIG. 18 Amniotic membrane market, application outlook: Key takeaways FIG. 19 Amniotic membrane market: application movement analysis FIG. 20 Surgical wounds market, 2014 - 2025 (USD Million) FIG. 21 Ophthalmology market, 2014 - 2025 (USD Million) FIG. 22 Others market, 2014 - 2025 (USD Million) FIG. 23 Amniotic membrane market, end use outlook: Key takeaways FIG. 24 Amniotic membrane market end use movement analysis FIG. 25 Hospitals, 2014 - 2025 (USD Million) FIG. 26 Ambulatory surgical centers market, 2014 - 2025 (USD Million) FIG. 27 Specialty clinics market, end use outlook: Key takeaways FIG. 28 Academic and research institutes market: End use movement analysis FIG. 29 Regional market place: Key takeaways FIG. 30 Regional outlook, 2017 & 2025
Speak to the report author to design an exclusive study to serve your research needs.
Your personal and confidential information is safe and secure.
